Friday, November 18, 2016

HIKAL

Another feather: HIKAL

About the company
Hikal is a reliable long-term partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry and is in the business of supplying research services, active ingredients and intermediates for its global customers. 

Hikal’s advanced manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad (Maharashtra). Hikal’s R&D facilities are located at Pune. The Pharmaceutical manufacturing facilities are situated in Jigani (Bangalore) and Panoli (Gujarat).

Business:
Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries. We collaborate with innovator companies and offer solutions in Contract Research, Custom Synthesis and Custom Manufacturing. Our people have extensive expertise in multi-disciplinary project management. Our continuous improvement plan has benefited our customers in the long run.

Areas of specialization are:
Discovery Research Support 
Hikal supply molecules for discovery research on a contract basis. They are the preferred partner of leading multinational companies in different phases of new drug discovery and development. 
Process Development 
Hikal have a successful track record in developing non-infringing processes and scaling them up from laboratory to kilo scale to commercial scale production. 
Their engineering expertise enables them to successfully set up chemical plants, manage and develop a wide range of processes that conform to stringent quality and safety guidelines.
Analytical Method Development
Hikal undertake method validation of new substances. 
The activities include in-process analysis, identification and quantification of impurities.
Custom Manufacturing 
Hikal undertake custom manufacturing of key intermediates and active substances for pharmaceutical and agrochemical companies worldwide. 
Their products are being used in new candidate drugs in Phase 1, Phase 2 and Phase 3 stage of clinical trials as well as in commercialized drugs.

Some Number crunching:
Annual results in brief
(Rs crore)
Mar ' 16
Mar ' 15
Mar ' 14
Mar ' 13
Mar ' 12
Sales
925.65
871.86
829.21
660.42
694.23
Operating profit
180.93
182.52
191.99
176.81
167.14
Interest
62.18
60.04
54.80
52.29
47.76